实用肝脏病杂志 ›› 2014, Vol. 17 ›› Issue (2): 180-183.doi: 10.3969/j.issn.1672-5069.2014.02.017

• 实验性肝炎 • 上一篇    下一篇

鸦胆子油注射液对H22细胞增殖的抑制作用及其机制探讨

宋艳丽,薛瑞,吴倩,张玉洁   

  1. 441021 湖北省襄阳市中心医院药学部
  • 收稿日期:2013-09-10 出版日期:2014-08-20 发布日期:2016-04-15
  • 通讯作者: 薛瑞 E-mail:22751520@qq.com
  • 作者简介:宋艳丽,女,37岁,大学本科,主管药师。主要从事医院药学研究。E-mail:rui67@sohu.com

Inhibition of proliferation of hepatoma cell line H22 cells by brucea oil in vitro and in vivo

Song Yanli,Xue Rui,Wu Qian,et al.   

  1. Department of Pharmacy,Municipal Central Hospital,Xiangyang 441021,Hubei Province
  • Received:2013-09-10 Online:2014-08-20 Published:2016-04-15

摘要: 目的 探讨鸦胆子油注射液在体内外对H22细胞增殖的抑制作用及其作用机制。方法 取H22细胞培养,采用MTT法检测鸦胆子油对细胞增殖的影响;应用H22细胞建立小鼠荷瘤模型,给予鸦胆子油治疗,计算抑瘤率、脾脏指数和胸腺指数,采用MTT法检测鸦胆子油对荷瘤小鼠脾细胞增殖的影响,采用双抗体夹心ABC-ELISA法检测荷瘤鼠血清TNF-α水平,采用放射免疫分析法检测转化生长因子(TGF)-α水平。结果 鸦胆子油在(10~160) μg/ml浓度范围内对H22细胞的增殖抑制率为34.1%~52.31%,与对照组比有统计学意义;给予鸦胆子油25和50 mg·kg-1灌胃后,荷瘤小鼠瘤质量分别为(1.095±0.301) g和(0.920±0.250) g,血清TGF-α分别为(11.172±0.639) pg/ml和(14.438±0.587) pg/ml,均较未治疗荷瘤动物显著下降[分别为(1.867±0.554) g和(16.354±0.762) pg/ml],TNF-α水平分别为(28.132±2.456) pg/ml和(26.521±3.267) pg/ml,较未治疗荷瘤动物显著升高[(20.231±2.614) pg/ml,P<0.05];与对照组比,无论是Con A还是LPS刺激,荷瘤动物脾细胞增殖受到抑制(P<0.05)。与荷瘤动物比,鸦胆子油体内给药则可促进脾细胞增殖,但对脾脏指数和胸腺指数无明显影响。结论 鸦胆子油体内外均能抑制肝癌H22细胞的生长,其抗肿瘤作用可能与改善荷瘤小鼠的脾细胞功能有关。

关键词: H22细胞, 鸦胆子油, 脾细胞, 肿瘤坏死因子-α, 转化生长因子-α

Abstract: Objective To investigate the inhibitory effect and related mechanisms of Brucea oil on proliferation of H22 hepatoma cell line. Methods H22 cells cultured in vitro were incubated with different concentration of Breucea oil (10~160 μg/ml) and cell proliferation was determined by MTT assay;Mice bearing H22 tumors were treated with Breacea oil for 10 days,and then the mice were scarified and tumor inhibitory rate, spleen index and thymus index were calculated;MTT was performed to detect the proliferation of spleen cells from tumor-bearing mice;The serum TNF-α was measured by enzyme-linked immunosorbent assay and serum transforming growth factor-α (TGF-α) levels by radioimmunoassay. Result The cell proliferation was inhibited by Brucea oil to 34.1%~52.31% of that of in the control at concentrations of 10 to 160 μg/ml;At concentration of 25 and 50 mg·kg-1,the tumor mass in tumor-bearing mice were reduced to (1.095±0.301) g and (0.920±0.250) g,respectively,and serum TGF-α levels decreased to(11.172±0.639) pg/ml and (14.438±0.587) pg/ml,respectively,significantly lower than those in non-treated tumor-bearing mice[(1.867±0.554) g and (16.354±0.762) pg/ml,respectively];In contrast,serum TNF-α levels increased to(28.132±2.456) pg/ml and(26.521±3.267)pg/ml,respectively,significantly higher than that in non-treated tumor-bearing mice[(20.231±2.614) pg/ml,P<0.05];Brucea oil also promoted the proliferation of spleen cells,but had no significant effect on the spleen index and thymus index as compared to those in tumor-bearing mice. Conclusion Brucea oil inhibits the proliferation of H22 cells in vitro and in vivo,and the anti-tumor effect might be related to the regulation of spleen cells in tumor-bearing mice.

Key words: H22 cell line, Brucea oil, Proliferation, Spleen cells, Tumor necrosis factor-α, Transforming growth factor-α